DOI QR코드

DOI QR Code

Hepatic Angiomyolipoma Presenting as a Hyperintense Lesion During the Hepatobiliary Phase of Gadoxetic Acid Enhanced-MRI: a Case Report

  • Jeong, Boryeong (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Kim, So Yeon (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Kang, Hyo Jeong (Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shin, Jinho (Department of Medicine, University of Ulsan College of Medicine)
  • Received : 2021.08.26
  • Accepted : 2021.11.11
  • Published : 2022.03.30

Abstract

Gadoxetic acid-enhanced magnetic resonance imaging (MRI) has been widely used to detect and characterize focal hepatic lesions. Because gadoxetic acid is a hepatocyte-specific contrast agent, its patterns during hepatobiliary phase enhancement provide useful information for differential diagnoses of focal hepatic lesions. Hepatic angiomyolipoma (AML) is a rare mesenchymal hepatic neoplasm composed of blood vessels, epithelioid cells, and varying amounts of adipose tissue components. Hepatic AMLs usually show marked hypointensity during the hepatobiliary phase of gadoxetic acid-enhanced MRI as hepatic AMLs are devoid of hepatocytes and fibrotic components. The present study describes a patient with hepatic AML and an atypical imaging feature. This tumor showed hyperintensity during the hepatobiliary phase of gadoxetic acid-enhanced MRI, mimicking hepatocellular tumors such as hepatocellular adenoma. The hepatobiliary hyperintensity of this lesion was likely due to multifocal entrapped hepatocytes resulting from an intrasinusoidal growth pattern of tumor cells and insufficient hepatic parenchymal enhancement during the hepatobiliary phase of gadoxetic acid-enhanced MRI.

Keywords

References

  1. Joo I, Lee JM. Recent advances in the imaging diagnosis of hepatocellular carcinoma: value of gadoxetic acid-enhanced MRI. Liver Cancer 2016;5:67-87 https://doi.org/10.1159/000367750
  2. Fujita N, Nishie A, Asayama Y, et al. Hyperintense liver masses at hepatobiliary phase gadoxetic acid-enhanced MRI: imaging appearances and clinical importance. Radiographics 2020;40:72-94 https://doi.org/10.1148/rg.2020190037
  3. Hui CL, Mautone M. Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI. Br J Radiol 2020;93:20190989 https://doi.org/10.1259/bjr.20190989
  4. World Health Organization Classification of Tumours Editorial Board. Digestive system tumours. 5th ed. World Health Organization: International Agency for Research on Cancer Publications, 2019:485-487
  5. Lee SJ, Kim SY, Kim KW, et al. Hepatic angiomyolipoma versus hepatocellular carcinoma in the noncirrhotic liver on gadoxetic acid-enhanced MRI: a diagnostic challenge. AJR Am J Roentgenol 2016;207:562-570 https://doi.org/10.2214/AJR.15.15602
  6. Kim R, Lee JM, Joo I, et al. Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Abdom Imaging 2015;40:531-541 https://doi.org/10.1007/s00261-014-0244-4
  7. Nonomura A, Enomoto Y, Takeda M, et al. Invasive growth of hepatic angiomyolipoma; a hitherto unreported ominous histological feature. Histopathology 2006;48:831-835 https://doi.org/10.1111/j.1365-2559.2006.02427.x
  8. Zhao C, Li X-y, Pan Y-h, Xie S-d, Zhou J, Chen J-n. Hepatic epithelioid angiomyolipoma with prominent invasive growth pattern: a hitherto unreported histopathologic eature which might promote misdiagnosis. Clin Diagn Pathol 2018;2:1-4
  9. Yoon JH, Lee JM, Kang HJ, et al. Quantitative assessment of liver function by using gadoxetic acid-enhanced MRI: hepatocyte uptake ratio. Radiology 2019;290:125-133 https://doi.org/10.1148/radiol.2018180753
  10. Unal E, Idilman IS, Karaosmanoglu AD, Ozmen MN, Akata D, Karcaaltincaba M. Hyperintensity at fat spared area in steatotic liver on the hepatobiliary phase MRI. Diagn Interv Radiol 2019;25:416-420 https://doi.org/10.5152/dir.2019.18535